Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Testing walking-focused rehabilitation intensity after stroke recovery

Compares intense and gentle walking-focused rehabilitation in adults recovering from stroke.

Plain-language title generated from the registry record
Registry title: Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)

Key facts

Where
Indianapolis, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT05727930, who can take part

Where in United States

  • Rehabilitation Hospital of IndianaIndianapolis, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Indiana University
Trial code
NCT05727930
Record updated
27 March 2026
Original description
The proposed research will evaluate the individual and combined effects of task-specificity and intensity of rehabilitation interventions on locomotor function, community mobility and quality of life in patients with subacute (1-6 months) post-stroke.Read full original descriptionShow less

Variable Intensive Early Walking Post-Stroke -2 (VIEWS-2)

The proposed research will evaluate the individual and combined effects of task-specificity and intensity of rehabilitation interventions on locomotor function, community mobility and quality of life in patients with subacute (1-6 months) post-stroke.

Inclusion: Sub-acute stroke (1-6 months); Hemiparesis (Fugl-Meyer <34) without cerebellar deficits; Ability to ambulate with or without physical assistance over 10 meters but < 1.0 m/s and assistive devices and below-knee bracing is allowed; Ability to sit > 30 seconds without upper-extremity support or physical assistance; Ability to follow 3-step commands; Provision of informed consent and medical clearance from a supervising physician or medical provider to participate; Must have the ability to consent or have a legal health care power of attorney or legally authorized representative to consent for participation on their behalf.

Exclusion: Significant cardiovascular, metabolic, or respiratory disease that limits exercise participation (e.g. previous myocardial infarction < 3 months prior, uncompensated congestive heart failure, resting blood pressure > 210/110 mmHg, uncontrolled diabetes, end-stage renal disease, severe infectious or psychiatry disease, or advanced malignancy); If during the graded-treadmill exercise evaluation, the participant presents with absolute criteria for termination of exercise testing during initial testing (e.g. moderate to severe angina, ST elevation > 1.0mm without preexisting Q wave secondary to prior MI, signs of poor perfusion, etc); Any orthopedic or neurological disorders that limited walking to <50m prior to stroke onset; Cannot receive physical therapy once baseline testing begins; If patients are prescribed botulinum toxin for their lower extremities will be excluded only if the dosage for any specific muscle is >50 units in leg muscles above the knee. If doses are > than 50 units in leg muscles below the knee, the participant will use an ankle-foot orthosis to minimze contributions of those mscles to locomotor function.

ClinicalTrials.gov NCT05727930